← Eichor
Study identifier: NCT06738576 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Allogeneic Use of Expanded Mesenchymal Stem Cells Derived From Adipose Tissue (HC106), Female Urinary Incontinence Women Over 50 Years Old

Condition: Urinary Incontinence Stress  ·  Sponsor: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

PhasePhase 1
Planned participants60
Who can joinFemale, 50 Years to no upper limit
Healthy volunteersNo

About this study

Evaluate the feasibility and safety, obtaining initial efficacy data, of expanded allogeneic mesenchymal stem cells derived from adipose tissue (HC106) for the treatment of urinary incontinence in women over 50 years of age.

This description comes directly from the study's public registry record.

Talk to the study team

Carmen González Enguita, PhD  ·  +34915504957  ·  cgenguita@fjd.es

Mariano García Arranz, PhD  ·  +34915504800  ·  mariano.garcia@quironsalud.es

Always discuss trial participation with your own doctor first.

Locations (6)

Hospital Universitario del HenaresCoslada, Madrid, SpainRecruiting
Fundación Jiménez DíazMadrid, Madrid, SpainRecruiting
Hospital Universitario Doce de OctubreMadrid, Madrid, SpainRecruiting
Hospital Universitario Rey Juan CarlosMóstoles, Madrid, SpainRecruiting
Hospital Universitario Infanta ElenaValdemoro, Madrid, SpainActive Not Recruiting
Hospital Universitario General de Villalba.Villalba, Madrid, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06738576